Bridge the Gap (BTG) - Black Youth Group for Suicide Prevention

This study, called Bridge the Gap (BTG) - Black Youth Group, is testing a new group program designed to help Black youth who are having thoughts of suicide. The program is based on an existing method called Collaborative Assessment & Management of Suicidality (CAMS) but is adapted to be culturally relevant. Researchers want to see if this group program is practical and well-received, and if it can help reduce suicidal thoughts and behaviors while increasing positive feelings like hope and a strong ethnic identity. You might be able to join if you are 12-17 years old, identify as Black or African American, and have had suicidal thoughts recently. The study plans to enroll 16 participants.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 16 participants.
What's involved
Participants will attend a 10-week group intervention and complete assessments before and after the treatment.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for approximately 3 months (22-23 weeks) after treatment to measure outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06880809

Bridge the Gap (BTG) - Black Youth Group

Recruiting
NAAges 12–17InterventionalPrevention
Children's Hospital Los Angeles
~16 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:Bridge the Gap (BTG) - Black Youth Group

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF)
Measured over From pre-treatment until 3 months post-treatment, approximately 23 weeks.
+7 more outcomes measured
Suicide Prevention
1 sites across 1 states
California1
  • Tia Tyndal, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital Los Angeles

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

12-17 years old
Identify as Black or African American or being of African descent
Have current suicidal ideation or suicidal ideation within the last 30 days
Have assent from the adolescent participant and consent from an individual's caregiver or guardian to participate.

Exclusion

An active psychotic disorder or current psychosis symptoms
No history of suicide attempt(s) or suicide ideation in the past 30 days
Cognitive deficits or a medical condition diagnosed from a medical provider that precludes full understanding of study materials as assessed through an inability to complete the pre-treatment CAMS SSF \& SSP
Caregivers, guardians, and/or the patient refuse to participate.
  • The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF)From pre-treatment until 3 months post-treatment, approximately 23 weeks.

    An assessment of suicide risk that consists of six core assessment constructs: psychological pain, stress, agitation, hopelessness, self-hate, and overall risk of suicide; as well as reasons for living and reasons for dying constructs, and wish to live and wish to die constructs.

  • Ethnic Identity Scale (EIS)From baseline until 3 months post-treatment, approximately 22 weeks.

    A 17-item scale that assesses the three components of ethnic identity and distinguishes between exploration, resolution, and affirmation. Scores range from 17-68, with higher scores indicating higher levels of affirmation, exploration, and resolution.

  • Living Ladder ScaleFrom baseline until 3 months post-treatment, approximately 22 weeks.

    A one-item measure that is prospectively associated with suicidal ideation and suicide attempts by measuring readiness to continue living among individuals thinking of suicide. Scores range from 0-8, with 8 indicating an individual is committed to making changes to make their lives worth living.

  • Brief Suicide Cognitions Scale (B-SCS)From baseline until 3 months post-treatment, approximately 22 weeks.

    A 6-item self-report scale that measures the suicidal belief system, including dimensions of unlovability, unbearability, and unsolvability. Scores range from 6-30, with lower scores indicating fewer suicide cognitions.

  • Therapeutic Relationship Working Alliance Inventory, Short Revised (WAI-SR)From baseline until 3 months post-treatment, approximately 22 weeks.

    A 12-item scale that reflects Bordin's three-dimensional conceptualization of therapeutic alliance: task, goal, and bond. Scores range from 12-60, with higher scores indicating higher therapeutic alliance.

  • Optimism and Hope Scale (OHS)From baseline until 3 months post-treatment, approximately 22 weeks.

    A 14-item scale that measures an individual's level of both optimism, as characterized by a positive outlook on the future, and hope, as characterized by the belief in one's ability to achieve goals and navigate challenges. Scores range from 14-56, with lower scores indicating more hope and optimism.

  • Parent Readiness for Hospital Discharge Scale (RHDS)From baseline until 3 months post-treatment, approximately 22 weeks.

    A 23-item scale aimed at providing a discharge readiness assessment before pediatric discharge from care in hospital settings. Scores range from 0-80, with higher scores indicating more readiness.

  • Group Cohesion ScaleFrom baseline until the beginning of post-treatment, approximately 10 weeks.

    A 12-item self-report scale that measures group cohesion, including dimensions of engagement, conflict, and avoidance. Scores across the subscales range from 0-72; higher scores indicate more of that dimension.